Clinical Trials for Kanglin Biotechnology

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kanglin Biotechnology

Clinical Trials (1)

NCT06280378
Β-Thalassemia Treatment with KL003 Cell Injection
PHASE1/PHASE2Recruiting
41 participants
Started: Apr 5, 2024 · Completed: May 31, 2027
1 condition1 sponsor2 locations